Previous 10 | Next 10 |
The following slide deck was published by Exact Sciences Corporation in conjunction with this Read more ...
REDWOOD CITY, Calif. , Nov. 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) announced that its stockholders voted to approve the company's proposed combination with Exact Sciences Corp (NASDAQ: EXAS) at a special meeting held earlier today. As previously announced...
Merger activity increased for the third week in a row with five new deals announced and ten deals closing. Four out of the five deals announced last week were valued at over $2 billion and two of them were rumored to be in the works before the actual announcement. Deal Statistics: New D...
NEW YORK , Nov. 4, 2019 /PRNewswire/ -- Shenandoah Telecommunications Co. (NASD: SHEN) will replace Genomic Health Inc. (NASD: GHDX) in the S&P SmallCap 600 effective prior to the open of trading on Friday, November 8 . Exact Sciences Corp. (NASD:EXAS) is acquiring Genomic Healt...
Option selling is a technique that professionals use to generate more income to portfolios and manage risk. Selling covered calls to take some premium income and set a price to sell a stock at should it rise further is a strategy that millions of investors already employ. Selling cash-secure...
MADISON, Wis. , Nov. 1, 2019 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will be presenting at the following investor conferences and invited investors to participate by webcast. Wolfe's Healthcare Conference, New York Presentation...
Image source: The Motley Fool. Exact Sciences Corp (NASDAQ: EXAS) Q3 2019 Earnings Call Oct 29, 2019 , 5:00 p.m. ET Operator Continue reading
Exact Sciences Corp (EXAS) Q3 2019 Results Earnings Conference Call October 29, 2019 5:00 PM ET Company Participants Megan Jones - Manager, Investor Relations Kevin Conroy - Chairman, President and Chief Executive Officer Jeff Elliott - Chief Financial Officer Mark Stenhouse ...
The following slide deck was published by Exact Sciences Corporation in conjunction with their 2019 Q3 earnings Read more ...
Exact Sciences (NASDAQ: EXAS ) Q3 results : More news on: Exact Sciences Corporation, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-04-15 11:30:02 ET William Blair analyst issues OUTPERFORM recommendation for EXAS on April 15, 2024 10:21AM ET. The previous analyst recommendation was Outperform. EXAS was trading at $68.965 at issue of the analyst recommendation. The overall analyst consensus : BU...
Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024. Mr. Bloomer brings to Exact Sciences more than 15 years of finance and accounting experience. ...
First analysis from ASCEND-2 confirms high detection rates and specificity achieved with multi-biomarker approach in most aggressive cancers and those with no standard-of-care screening test 1 Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic t...